Alexandra Ellervik
Investor Relations Contact bij CHOSA ONCOLOGY AB
Profiel
Alexandra Ellervik is currently the Head of Communication & Investor Relations at Chosa Oncology AB.
Previously, she worked as an Investor Relations & Press Contact at RhoVac AB.
Actieve functies van Alexandra Ellervik
| Bedrijven | Functie | Begin |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Contact | - |
Eerdere bekende functies van Alexandra Ellervik
| Bedrijven | Functie | Einde |
|---|---|---|
| CHOSA ONCOLOGY AB | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHOSA ONCOLOGY AB | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
